+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cough And Cold Preparations Global Market Report 2020

  • ID: 4871568
  • Report
  • December 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble
  • MORE
Cough And Cold Preparations Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global cough and cold preparations market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the cough and cold preparations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cough And Cold Preparations Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market:
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Drug Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others 2) By Dosage Type: Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Others 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
  • Companies Mentioned: AstraZeneca , Bayer , Blackmores Limited, Dabur, GlaxoSmithKline
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble
  • MORE
1. Executive Summary

2. Cold and Cough Preparations Market Characteristics

3. Cold and Cough Preparations Market Size And Growth
3.1. Global Cold and Cough Preparations Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Cold and Cough Preparations Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Cold and Cough Preparations Market Segmentation
4.1. Global Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others
4.2. Global Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral Syrups
  • Tablets/Pills
  • Nasal Drops
  • Lozenges
  • Others
4.3. Global Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
5. Cold and Cough Preparations Market Regional And Country Analysis
5.1. Global Cold and Cough Preparations Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Cold and Cough Preparations Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Cold and Cough Preparations Market
6.1. Asia-Pacific Cold and Cough Preparations Market Overview
6.2. Asia-Pacific Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Cold and Cough Preparations Market
7.1. China Cold and Cough Preparations Market Overview
7.2. China Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.4. China Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Cold and Cough Preparations Market
8.1. India Cold and Cough Preparations Market Overview
8.2. India Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.4. India Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Cold and Cough Preparations Market
9.1. Japan Cold and Cough Preparations Market Overview
9.2. Japan Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.4. Japan Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Cold and Cough Preparations Market
10.1. Australia Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.3. Australia Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Cold and Cough Preparations Market
11.1. Indonesia Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.3. Indonesia Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Cold and Cough Preparations Market
12.1. South Korea Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.3. South Korea Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Cold and Cough Preparations Market
13.1. Western Europe Cold and Cough Preparations Market Overview
13.2. Western Europe Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.4. Western Europe Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Cold and Cough Preparations Market
14.1. UK Cold and Cough Preparations Market Overview
14.2. UK Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.4. UK Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Cold and Cough Preparations Market
15.1. Germany Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.3. Germany Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Cold and Cough Preparations Market
16.5. France Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.6. France Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.7. France Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Cold and Cough Preparations Market
17.1. Eastern Europe Cold and Cough Preparations Market Overview
17.2. Eastern Europe Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Cold and Cough Preparations Market
18.1. Russia Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.3. Russia Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Cold and Cough Preparations Market
19.1. North America Cold and Cough Preparations Market Overview
19.2. North America Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.4. North America Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Cold and Cough Preparations Market
20.1. USA Cold and Cough Preparations Market Overview
20.2. USA Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.4. USA Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Cold and Cough Preparations Market
21.1. South America Cold and Cough Preparations Market Overview
21.2. South America Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.4. South America Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Cold and Cough Preparations Market
22.1. Brazil Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.3. Brazil Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Cold and Cough Preparations Market
23.1. Middle East Cold and Cough Preparations Market Overview
23.2. Middle East Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.4. Middle East Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Cold and Cough Preparations Market
24.1. Africa Cold and Cough Preparations Market Overview
24.2. Africa Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Cold and Cough Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.4. Africa Cold and Cough Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Cold and Cough Preparations Market Competitive Landscape And Company Profiles
25.1. Cold and Cough Preparations Market Competitive Landscape
25.2. Cold and Cough Preparations Market Company Profiles
25.2.1. AstraZeneca
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Bayer
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Blackmores Limited
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Dabur
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. GlaxoSmithKline
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Cold and Cough Preparations Market

27. Cold and Cough Preparations Market Trends And Strategies

28. Product Pipeline Analysis

29. Cold and Cough Preparations Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble
  • MORE
The cold and cough preparations market consists of sales of drugs for cold and cough. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. In this market, sales of antihistamines, antibiotics, decongestants, expectorants and bronchodilators are also included.

The global cough and cold preparations market was valued at about $23.2 billion in 2018 and is expected to grow to $26.61 billion at a CAGR of 3.5% through 2022.

The cold and flu season is the major driver of sales for products related to prevention and treatment of cold and cough. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages. According to a research study, rhinoviruses replicates more efficiently at temperatures lower than 37°C, or 98.6°F, which is the average core body temperature in humans. The temperature inside the nasal cavity is approximately 33°C (91.4°F), which may make it an ideal breeding ground for rhinoviruses. Although flu viruses are generally present year-round, they are most common during the fall and winter seasons. Therefore, sales of vaccines and other drug products that help alleviate the symptoms of colds and cough, and products which help the body naturally prevent and treat cold and flu symptoms is driving the market for cold and cough drugs.

Threat from substitute products such as generic and counterfeit drugs, is significantly restraining the global cold and cough preparations market. Pharmaceutical companies invest a large sum of money in drug development process. Once a drug candidate is developed and approved by the regulatory authorities, companies patent their inventions to protect their intellectual property. During the patency period, the company holding the patent holds exclusivity for manufacturing and distribution. Post expiration of patency, generic versions of the drugs are manufactured by other companies. The prices of the generics are very low in comparison to the original brand of the drug. According to an article of Alpha Invesco, a new FDA-approved blockbuster drug that netted $100 million a year in profit during its patent protection duration could become one that earns only $1 million a year in profit overnight after losing its patent. Additionally, there is a major international problem with counterfeit drugs. The best of these counterfeits duplicates a real drug’s formula and sells it at a lower price, which hurts pharmaceutical companies' profits. Moreover, the counterfeits made with low-grade materials can destroy the reputations of the legitimate products, thus affecting the growth of the market.

Advancements in technologies are driving the global pharmaceutical sector including cold and cough preparations. According to global life sciences report by Deloitte, adoption of AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine are the major technologies driving the life sciences sector. AI technology is being used in diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is allowing new business models to emerge and enhancing customer experiences. Pharmaceutical companies are also increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators which are objectively measured and evaluated for biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.

The cold and cough preparations market is regulated by authorities such as the Food and Drug Administration in the US. For instance, in November 2018, the Food and Drug Administration (FDA) restricted the use of codeine in children. Codeine is approved to treat pain and cough but this medicine carry serious risks, including slowed or difficult breathing and can be potentially fatal. This risk is greater in children younger than 12 years but the use of codeine should also be limited in some older children. Single-ingredient codeine is FDA-approved only for use in adults. FDA is also recommending against the use of codeine in breastfeeding mothers due to possible harm to their infants.

Major players in the market are AstraZeneca , Bayer , Blackmores Limited, Dabur, GlaxoSmithKline
Note: Product cover images may vary from those shown
5 of 5
  • AstraZeneca
  • Bayer
  • Blackmores Limited
  • Dabur
  • GlaxoSmithKline
  • Himalaya Global Holdings
  • Hyland's
  • Johnson & Johnson
  • Novartis
  • Perrigo Company
  • Pfizer
  • Prestige Brands
  • Procter & Gamble
  • Reckitt Benckiser
  • Sun Pharmaceutical Industries
  • Taro Pharmaceutical Industries Ltd
  • Tris Pharma Inc
  • Tsumura & Co
  • Aaron Industries Inc.
  • AccuMed Inc.
  • Acella Pharmaceuticals LLC
  • Amneal Pharmaceuticals LLC
  • Atley Pharmaceuticals
  • Aurobindo Pharma Ltd
  • Aytu BioScience Inc.
  • Biozone Laboratories Inc.
  • Boiron Group
  • Charleston Laboratories Inc
  • Emami Ltd. (Zandu Pharmaceutical Works Ltd)
  • Exscientia Ltd
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll